Medical devices, healthcare technology and the business of care
510(k) clearance · K260613

AMI Plasma Cartridge, AMI

Sequitur Health Corp. · Decision date Sep 1, 2026

MEDTECHLEDGER EXPLANATIONK260613

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 2026-09-01 for K260613, a traditional 510(k) submitted by Sequitur Health Corp. of Phoenix, Arizona, and received on 02/25/2026. The device is listed as AMI™ Plasma Cartridge, AMI™, under the classification name Photometric Method, Ammonia, regulation number 862.1065, with primary product code JID and subsequent product code JJE. The review panel and regulation medical specialty are both Clinical Chemistry. SESE indicates clearance to market, not PMA approval.

A separate establishment registration and device listing tied to the same submission names the proprietary products AMI and AMI Plasma Cartridge under product code JJE, classification ANALYZER, CHEMISTRY (PHOTOMETRIC, DISCRETE), FOR CLINICAL USE, regulation 862.2160, device class 1. Sequitur Health Corp. is recorded as manufacturer and complaint file establishment. The source pages do not state the specific component, reagent, or change assessed, the predicate device, or any performance data, so the technical basis for the equivalence finding remains unknown.

The record does not include the decision summary content, indications for use, or labeling, and no clinical or analytical performance conclusions should be drawn from the clearance alone.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Clinical Chemistry
Decision date
Sep 1, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K260613
Regulatory pathway
510(k) premarket notification
Product code
JID
Decision code
SESE
Decision date
Sep 1, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Photometric Method, Ammonia.

Product code
JID
FDA device class
1

FDA decision timeline

  1. K260613 received

    Application receipt date recorded by FDA.

  2. K260613 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Sequitur Health Corp.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Phoenix, AZ

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records